**Core Concept**
The question is testing the knowledge of 5HT3 antagonists used in the management of chemotherapy-induced nausea and vomiting (CINV). 5HT3 antagonists are a class of drugs that block the action of serotonin at the 5-HT3 receptors in the central nervous system and the gastrointestinal tract, thereby preventing nausea and vomiting.

**Why the Correct Answer is Right**
The correct answer is **Ondansetron**. Ondansetron is a potent 5HT3 antagonist that has a high affinity for the 5-HT3 receptors. It is widely used in the management of CINV due to its efficacy and safety profile. Ondansetron works by blocking the action of serotonin at the 5-HT3 receptors in the central nervous system and the gastrointestinal tract, thereby preventing nausea and vomiting.

**Why Each Wrong Option is Incorrect**
**Option A:** **Granisetron** is also a 5HT3 antagonist, but it has a lower potency compared to ondansetron. It is still used in the management of CINV, but it is not as effective as ondansetron.

**Option B:** **Tropisetron** is another 5HT3 antagonist, but it has a different pharmacokinetic profile compared to ondansetron. It is used in the management of CINV, but it is not as potent as ondansetron.

**Option D:** **Palonosetron** is a more recent 5HT3 antagonist that has a higher potency and a longer duration of action compared to ondansetron. However, it is not the most potent 5HT3 antagonist available.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the choice of 5HT3 antagonist should be based on the individual patient's needs and the specific clinical scenario. The most potent 5HT3 antagonist may not always be the best choice, and the clinician should consider factors such as efficacy, safety, and cost when making a decision.

**Correct Answer:** D. Palonosetron